Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

ONC Insider Trading (Oncimmune)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £9,971.72
Insider Selling (Last 12 Months): £180,000

Oncimmune Insider Trading History Chart

This chart shows the insider buying and selling history at Oncimmune by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncimmune Share Price & Price History

Current Price: GBX 190
Price Change: Price Increase of +7 (3.83%)
As of 09/17/2021 01:00 AM ET

This chart shows the closing price history over time for ONC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

Oncimmune Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/11/2021Cheung ToInsiderSell40,000GBX 185£74,000
1/8/2021Cheung ToInsiderSell10,000GBX 185£18,500
1/5/2021Cheung ToInsiderSell50,000GBX 175£87,500
12/17/2020Adam HillInsiderBuy5,764GBX 173£9,971.72
6/4/2020Meinhard SchmidtInsiderBuy13,000GBX 188£24,440
5/4/2020Carsten SchroederInsiderBuy18,000GBX 85£15,300
4/24/2020Matthew HallInsiderBuy1,176GBX 85£999.60
4/7/2020Matthew HallInsiderBuy9,487GBX 53£5,028.11
4/1/2020Adam HillInsiderBuy21,321GBX 47£10,020.87
3/24/2020Meinhard SchmidtInsiderBuy18,000GBX 49£8,820
3/10/2020Geoffrey Neil Hamilton-FairleyInsiderSell25,000GBX 70£17,500
See Full Table
Insider Selling at Oncimmune?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Oncimmune and related companies.

SEC Filings (Institutional Ownership Changes) for Oncimmune (LON:ONC)

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers that can help stratify patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID disease-specific stratification panels. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
Read More on Oncimmune

Today's Range

Now: GBX 190
Low: 181.43
High: 190

50 Day Range

MA: GBX 182.42
Low: 158.90
High: 195

52 Week Range

Now: GBX 190
Low: 137.51
High: 261.63

Volume

4,715 shs

Average Volume

108,482 shs

Market Capitalization

£131.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Oncimmune?

Oncimmune's top insider shareholders include:
  1. Adam Hill (Insider)
  2. Carsten Schroeder (Insider)
  3. Cheung To (Insider)
  4. Geoffrey Neil Hamilton-Fairley (Insider)
  5. Matthew Hall (Insider)
  6. Meinhard Schmidt (Insider)
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel